top of page
News
Theolytics presents CAF-targeting therapy for stromal rich tumours, and strengthens leadership team
Oxford, UK, 6th October 2022 - Theolytics, a biotechnology company harnessing viruses to combat disease, will release data on their...
Oct 6, 2022
bottom of page